Interleukin-41 as a biomarker of the anti-inflammatory response associated with hyperuricemia

Zhang, Shujie; Huang, Guoqing; Li, Mingcai; Mao, Yushan; Li, Yan

doi:10.1016/j.imlet.2023.11.003

Immunology Letters

2023

DOI: 10.1016/j.imlet.2023.11.003

|View full text |Cite

Interleukin-41 as a biomarker of the anti-inflammatory response associated with hyperuricemia

Shujie Zhang,

Guoqing Huang,

Mingcai Li

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

(1 citation statement)

References 34 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The third family includes interleukin 17A, B, C, D, F, and IL-8, 25 and 27, as well as IL-31, 32, and 33. The number of described interleukins is still growing: in 2016, 38 interleukins were described, and in 2023, 41 [37,38].…”

mentioning

confidence: 99%

Potential Aspects of the Use of Cytokines in Atopic Dermatitis

Krupka-Olek,

Bożek,

Aebisher

et al. 2024

Biomedicines

View full text Add to dashboard Cite

Atopic dermatitis (AD) is an abnormal inflammatory response in the skin to food, environmental IgE, or non-IgE allergens. This disease belongs to a group of inflammatory diseases that affect both children and adults. In highly developed countries, AD is diagnosed twice as often in children than in adults, which may possibly be connected to increased urbanization. The immune system’s pathomechanisms of AD involve humoral mechanisms with IgE, cellular T lymphocytes, dendritic cells occurring in the dermis, Langerhans cells occurring in the epidermis, and other cells infiltrating the site of inflammation (eosinophils, macrophages, mast cells, neutrophils, and basophils). Cytokines are small proteins that affect the interaction and communication between cells. This review characterizes cytokines and potential aspects of the treatment of atopic dermatitis, as well as new strategies that are currently being developed, including targeting cytokines and their receptors.

show abstract

mentioning

confidence: 99%

Potential Aspects of the Use of Cytokines in Atopic Dermatitis

Krupka-Olek,

Bożek,

Aebisher

et al. 2024

Biomedicines

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Interleukin-41 as a biomarker of the anti-inflammatory response associated with hyperuricemia

Cited by 1 publication

References 34 publications

Potential Aspects of the Use of Cytokines in Atopic Dermatitis

Potential Aspects of the Use of Cytokines in Atopic Dermatitis

Contact Info

Product

Resources

About